The Genomate Health Team

Istvan Petak

Founder & CSO

Dr. Istvan Petak is an international expert in precision oncology and molecular pharmacology of targeted therapies with over 30 years of experience.

He is the founder and CSO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC). He started his molecular pathology and signal transduction therapy career at Semmelweis University and St. Jude Children's Research Hospital (Memphis, TN). His main achievements are exploring the role of apoptotic pathways in individual drug sensitivity, pioneering molecular companion diagnostics of the EGFR gene in 2003, and implementing NGS (next-generation sequencing) in precision oncology in 2008. He is the lead inventor of a novel computational method, published in 2021, for standardized, personalized treatment recommendations that has won numerous recognitions from organizations, including DIGITALEUROPE and ASCO.

Our Executive Team

Nabil Hafez

CEO

Nabil Hafez, MSc, MBA, is a seasoned leader in precision medicine with 20+ years in genomics, diagnostics, and healthcare software. He led key efforts at the Broad Institute on the Human Genome Project and held leadership roles at PierianDx, Sunquest, Quest Diagnostics, and GenomeQuest. Nabil has successfully driven the global commercialization of NGS and precision oncology platforms.

Close

Ioana Stupariu

CAO & General Counsel

Ioana Stupariu, LLM, MBA, leads legal, compliance, and operations at Genomate Health, bringing 15 years of experience in tech regulation and privacy. She’s advised deep tech startups, served as DPO for a major automotive group, and lectured on EU law. Her academic work focuses on data governance in healthcare innovation, aligning regulatory strategy with Genomate Health’s mission.

Close

Peter Filotas

CTO

Peter Filotas brings 15 years of experience in software engineering, agile development, and biotech. At Genomate Health, he leads the development of proprietary computational reasoning technology, managing teams of developers and bioinformaticians. Formerly with Oncompass Medicine, Porsche Informatik, and iWiW, Peter has built and scaled high-load systems and mission-critical healthcare software platforms.

Close

Orsolya Peter

Director of Human Resources

Orsolya Peter drives people and culture at Genomate Health, aligning talent strategy with the company’s mission to transform cancer care through precision oncology. With 25 years of HR leadership, including at Healcloud and GE, she brings deep expertise in scaling teams, fostering inclusion, and building high-impact, collaborative environments that empower innovation in healthcare and biotech.

Close

Attila Mézes

Director of Finance

Attila Mézes leads finance at Genomate Health, bringing decades of experience in healthcare and investment. Known for his strategic vision, he has held leadership roles at Oncompass Medicine, PwC, KBC Securities, and more. Attila’s deep expertise in financial strategy and operations supports Genomate Health’s mission to expand access to precision oncology and drive sustainable growth in healthcare innovation.

Close

Barbara Vodicska, PhD

Head of Translational Science

Barbara Vodicska, PhD, is a biochemical engineer with deep expertise in the molecular biology of prion diseases and cancer. She earned her PhD at the German Cancer Research Center (DKFZ) in Heidelberg. At Genomate Health, she leads translational science efforts, advancing computational reasoning solutions to optimize targeted therapy decisions in precision oncology.

Close

Robert Doczi, PhD

Head of Research

Dr. Istvan Petak is a renowned expert in precision oncology with over 25 years of experience. He founded Genomate Health and Oncompass Medicine, and serves as adjunct professor at UIC. He pioneered EGFR diagnostics in 2003 and introduced NGS to oncology in 2008. His patented computational reasoning method for personalized treatment planning has earned recognition from ASCO, DIGITALEUROPE, and others.

Close

Dora Lakatos

Head of Computational Science

Dora Lakatos, PhD, leads computational science at Genomate Health, applying advanced modeling and machine learning to power the company’s precision oncology platform. With a PhD in biophysics, she brings deep expertise in biomedical data analysis, tumor biology, and quantitative modeling. Her work bridges computational insight with biological relevance to drive innovation in personalized cancer care.

Close

Dora Tihanyi

Head of Product

Dora Tihanyi leads product development at Genomate Health, bringing a unique background in info-bionics and molecular diagnostics. With a BSc and MSc in Info-Bionics Engineering, she previously held key roles at Oncompass Medicine, including Product Owner and Interpretation Team Leader. Her work ensures Genomate aligns with the needs of clinicians and patients in precision oncology.

Close

Our Advisory Board

Wiliam T. Beck, PhD

Scientific Advisor

Dr. Beck is a Professor Emeritus at UIC with 50+ years in molecular pharmacology. A leader in cancer research, he’s advised the NIH, the AACR, and pioneered drug resistance studies and therapeutic target discovery in ovarian and breast cancers.

Close

Irving Levy, CPA

Financial Advisor

Irving Levy is a seasoned financial leader with nearly 40 years of experience in healthcare, startups, and philanthropy. He played a key role in scaling Exigence Group to $120M, led its sale to TeamHealth, and now advises Genomate Health and early-stage ventures.

Close

Nabil Hafez

Chief Executive Officer

Nabil Hafez, MSc, MBA, is a seasoned leader in precision medicine with 20+ years in genomics, diagnostics, and healthcare software. He led key efforts at the Broad Institute on the Human Genome Project and held leadership roles at PierianDx, Sunquest, Quest Diagnostics, and GenomeQuest. Nabil has successfully driven the global commercialization of NGS and precision oncology platforms.

Ioana Stupariu

Chief of Staff & Head of Legal

Ioana Stupariu, LLM leads legal, compliance, and operations at Genomate Health, bringing 15 years of experience in project management, tech regulation and regulatory compliance. She is an advisor for deep tech startups, served as DPO for a major automotive group, and is the founder of a boutique consulting firm serving CEE tech-driven companies to comply with regulatory requirements.

Peter Filotas

Chief Technology Officer

Peter Filotas brings 15 years of experience in software engineering, agile development, and biotech. At Genomate Health, he leads the development of proprietary computational reasoning technology, managing teams of developers and bioinformaticians. Formerly with Oncompass Medicine, Porsche Informatik, and iWiW, Peter has built and scaled high-load systems and mission-critical healthcare software platforms.

Orsoyla Peter

Director of Human Resources

Orsolya Peter drives people and culture at Genomate Health, aligning talent strategy with the company’s mission to transform cancer care through precision oncology. With 25 years of HR leadership, including at Healcloud and GE, she brings deep expertise in scaling teams, fostering inclusion, and building high-impact, collaborative environments that empower innovation in healthcare and biotech.

Attila Mezes

Director of Finance

Attila Mezes leads finance at Genomate Health, bringing decades of experience in healthcare and investment. Known for his strategic vision, he has held leadership roles at Oncompass Medicine, PwC, KBC Securities, and more. Attila’s deep expertise in financial strategy and operations supports Genomate Health’s mission to expand access to precision oncology and drive sustainable growth in healthcare innovation.

Barbara Vodicska

Head of Translational Science

Barbara Vodicska, PhD, is a biochemical engineer with deep expertise in the molecular biology of prion diseases and cancer. She earned her PhD at the German Cancer Research Center (DKFZ) in Heidelberg. At Genomate Health, she leads translational science efforts, advancing computational reasoning solutions to optimize targeted therapy decisions in precision oncology.

Robert Doczi

Head of Research

Robert Doczi, PhD, is a molecular biologist with over 20 years’ experience in cellular signaling. At Genomate Health, he is involved in the development and clinical validation of a novel computational method that implements cognitive computing in precision oncology. Previously, he was a postdoctoral researcher at Vienna Biocenter (Austria), was a Marie Curie Fellow at Royal Holloway, University of London (UK), and was a principal investigator at the Hungarian Academy of Sciences.

Dora Lakatos

Head of Computational Science

Dora Lakatos, PhD, leads computational science at Genomate Health, applying advanced modeling and machine learning to power the company’s precision oncology platform. With a PhD in biophysics, she brings deep expertise in biomedical data analysis, tumor biology, and quantitative modeling. Her work bridges computational insight with biological relevance to drive innovation in personalized cancer care.

Dora Tihanyi

Head of Product

Dora Tihanyi leads product development at Genomate Health, bringing a unique background in info-bionics and molecular diagnostics. With a BSc and MSc in Info-Bionics Engineering, she previously held key roles at Oncompass Medicine, including Product Owner and Interpretation Team Leader. Her work ensures Genomate aligns with the needs of clinicians and patients in precision oncology.

Advisors

William T. Beck, PhD

Scientific Advisor

Dr. Beck is a Professor Emeritus at UIC with 50+ years in molecular pharmacology. A leader in cancer research, he’s advised the NIH, the AACR, and pioneered drug resistance studies and therapeutic target discovery in ovarian and breast cancers.

Irving Levy, CPA

Finance & Administration Advisor

Irving Levy is a seasoned financial leader with nearly 40 years of experience in healthcare, startups, and philanthropy. He played a key role in scaling Exigence Group to $120M, led its sale to TeamHealth, and now advises Genomate Health and early-stage ventures.

Our Board

Dr. Istvan Petak

Physician-Scientist

30+ years in precision oncology

Dr. Richard Schwab

Physician-Scientist

Gastroenterologist, Entrepreneur

Jared Schrieber

Physician-Scientist

Silicon Valley Digital Unicorn Founder and Entrepreneur

Dr. Lazlo Mechtler

Oncologists and Neurologists

Chief Oncologist at Roswell Park Cancer Center;
CMO at Dent Clinic

Scott Friedman

Lawyer in Healthcare

Partner at Lippes Mathias LLP

Let’s outsmart cancer. Together.

At Genomate Health, our leadership team consists of industry leaders, senior innovators, and smart advisory specialists who are passionate about making a positive impact in the world. With their combined decades of experience in healthcare, technology, and business, our team is dedicated to transforming cancer care and improving outcomes for all patients.

If you are looking for a fulfilling career that makes a difference in the world,
join the team that is changing cancer care, one patient at a time.

Explore Open Roles